Randomized controlled studies should further investigate the effects of DAs in specific PCOS phenotypes as well as explore unaddressed possibilities, such as the use of tricyclic antidepressants with an already low degree of evidence for their potential to modulate PRL levels. Here, PRL is linked to polycystic ovary syndrome.